Advances in Pharma Business Management and Research [[electronic resource] ] : Volume 1 / / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Autore: |
Schweizer Lars
|
| Titolo: |
Advances in Pharma Business Management and Research [[electronic resource] ] : Volume 1 / / edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen
|
| Pubblicazione: | Springer Nature, 2020 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | |
| Edizione: | 1st ed. 2020. |
| Descrizione fisica: | 1 online resource (X, 85 p. 11 illus.) |
| Disciplina: | 615.19 |
| Soggetto topico: | Pharmaceutical technology |
| Health care management | |
| Health services administration | |
| Medical laws and legislation | |
| Pharmacy | |
| Pharmacy management | |
| Pharmaceutical Sciences/Technology | |
| Health Care Management | |
| Medical Law | |
| Pharmacoeconomics and Health Outcomes | |
| Soggetto non controllato: | Pharmaceutical Sciences/Technology |
| Health Care Management | |
| Medical Law | |
| Pharmacy | |
| Pharmacoeconomics and Health Outcomes | |
| Pharmaceutics | |
| Health Care | |
| Pharmacology | |
| Pharma Management | |
| Market Access | |
| Regulatory Affairs | |
| Research & Development | |
| Quality Control | |
| Open Access | |
| Industrial chemistry & chemical engineering | |
| Health economics | |
| Medical & healthcare law | |
| Pharmacy / dispensing | |
| Persona (resp. second.): | SchweizerLars |
| DingermannTheodor | |
| RusseOtto Quintus | |
| JansenChristian | |
| Nota di contenuto: | Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management. |
| Sommario/riassunto: | This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business. |
| Titolo autorizzato: | Advances in Pharma Business Management and Research |
| ISBN: | 3-030-35918-2 |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910380742003321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |